Vanguard Capital Management
PLSE icon

Vanguard Capital Management’s Pulse Biosciences PLSE Stock Holding History

Vanguard Capital Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.9M Sell
788,640
-27,212
-3% -$642K ﹤0.01% 2402
2026
Q1 		$17.6M Buy
+815,852
New +$15.1M ﹤0.01% 2417

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management's PLSE Position: Q2 2026 in Review

Vanguard Capital Management reduced its Pulse Biosciences (PLSE) stake by 3.3% in Q2 2026, selling an estimated $642K and leaving 788,640 shares worth $21.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2402.

Vanguard Capital Management first reported a position in PLSE in Q1 2026 and has held it in 2 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Vanguard Capital Management held 788,640 shares of Pulse Biosciences worth $21.9M as of Q2 2026.
  • Vanguard Capital Management sold 27,212 Pulse Biosciences shares in Q2 2026, an estimated $642K.
  • Pulse Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2402 holding.
  • Vanguard Capital Management first reported a position in Pulse Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.